MA45367B1 - Tyrosine kinase inhibitors - Google Patents
Tyrosine kinase inhibitorsInfo
- Publication number
- MA45367B1 MA45367B1 MA45367A MA45367A MA45367B1 MA 45367 B1 MA45367 B1 MA 45367B1 MA 45367 A MA45367 A MA 45367A MA 45367 A MA45367 A MA 45367A MA 45367 B1 MA45367 B1 MA 45367B1
- Authority
- MA
- Morocco
- Prior art keywords
- tyrosine kinase
- kinase inhibitors
- compounds
- btk
- inhibitors
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des composés qui sont des inhibiteurs de la tyrosine kinase, en particulier des inhibiteurs de la tyrosine kinase de bruton ("btk"), et sont par conséquent utiles pour le traitement de maladies pouvant être traitées par l'inhibition de la btk telle que le cancer, les maladies auto-immunes, inflammatoires, et thromboemboliques. L'invention concerne également des compositions pharmaceutiques contenant de tels composés et des procédés de préparation de tels composés.The present invention relates to compounds which are inhibitors of tyrosine kinase, in particular inhibitors of bruton tyrosine kinase ("btk"), and therefore are useful for the treatment of diseases treatable by inhibition of the. btk such as cancer, autoimmune, inflammatory, and thromboembolic diseases. The invention also relates to pharmaceutical compositions containing such compounds and to methods of preparing such compounds.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562170547P | 2015-06-03 | 2015-06-03 | |
PCT/US2016/035588 WO2016196840A1 (en) | 2015-06-03 | 2016-06-02 | Tyrosine kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MA45367B1 true MA45367B1 (en) | 2021-09-30 |
Family
ID=59724528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA45367A MA45367B1 (en) | 2015-06-03 | 2016-06-02 | Tyrosine kinase inhibitors |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR104865A1 (en) |
EC (1) | ECSP18000097A (en) |
MA (1) | MA45367B1 (en) |
-
2016
- 2016-06-02 AR ARP160101618A patent/AR104865A1/en active IP Right Grant
- 2016-06-02 MA MA45367A patent/MA45367B1/en unknown
-
2018
- 2018-01-02 EC ECIEPI201897A patent/ECSP18000097A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR104865A1 (en) | 2017-08-23 |
ECSP18000097A (en) | 2018-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA49809A1 (en) | Compounds used as kinase inhibitors | |
ZA201708667B (en) | Tyrosine kinase inhibitors | |
MA39219B1 (en) | New lrrk2 Kinase Inhibitor Compounds Used to Treat Parkinson's, Alzheimer's and Amyotrophic Lateral Sclerosis | |
MA40111B1 (en) | Derivatives of tetrahydronaphthalene inhibiting mcl-1 protein | |
CR20220169A (en) | Bicyclic heterocycles as fgfr inhibitors | |
EA202091709A1 (en) | DNA PC INHIBITORS | |
TN2014000420A1 (en) | INDOLE AND INDAZOLE DERIVATIVES THAT ACTIVATE MPK | |
MA40768A (en) | MONO OR DI-SUBSTITUTE INDOLE DERIVATIVES AS DENGUE VIRUS REPLICATION INHIBITORS | |
EA202091708A1 (en) | DNA PC INHIBITORS | |
MA41238A (en) | DERIVATIVES 5 - [(PIPERAZIN-1-YL) -3-OXO-PROPYL] -IMIDAZOLIDINE-2,4-DIONE AS ADAMT INHIBITORS FOR THE TREATMENT OF OSTEOARTHRIT | |
MA38284B1 (en) | Inhibitors of 2,3-dihydroimidazol [1,2-c] pyrimidin-5 (1 h) -one-2-lipoprotein-associated phospholipase (lp-pla2) | |
MA40875A (en) | 2,4-DIAMINO-QUINOLEIN SUBSTITUTED AS NEW ANTI-CANCER AGENTS | |
PH12021550743A1 (en) | Boron containing pde4 inhibitors | |
MA42776B1 (en) | Compounds useful for inhibiting t-ror | |
MA40366A (en) | TETRAHYDROQUINOLINE DERIVATIVES AS BROMODOMA INHIBITORS | |
MX2022008627A (en) | Substituted pyrazolo-pyrimidines and uses thereof. | |
MA38678A1 (en) | Nucleoside derivatives 4'-azido, 3'-deoxy-3'-fluoro substituted | |
MA39253B1 (en) | Substituted bicyclic heteroaryl compounds used as rxr agonists | |
MA45367B1 (en) | Tyrosine kinase inhibitors | |
MA35860B1 (en) | Quinoline derivatives as pde10a enzyme inhibitors | |
MA43507B1 (en) | Mono or di-substituted indole derivatives as dengue virus replication inhibitors | |
MA49994B1 (en) | Macrocyclic compounds for the treatment of disease | |
MA54770A1 (en) | Compounds used as kinase inhibitors | |
MA42175B1 (en) | Pyrazolopyrimidine derivatives as btk inhibitors for cancer treatment | |
MA51297B1 (en) | Quinazolinones as parp14 inhibitors |